We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacological treatment of patients with advanced prostate cancer.
- Authors
Turner, Bruce; Drudge-Coates, Lawrence
- Abstract
Prostate cancer is linked to the male sex hormone testosterone. In advanced disease, blocking the production of testosterone using androgen deprivation therapy causes regression of prostate cancer and minimises or prevents symptoms associated with the disease. Luteinising hormone-releasing hormone agonists are commonly used in the management of prostate cancer, however less is known about the role of the newer gonadotrophin-releasing hormone (GnRH) antagonists. This article focuses on the differences between the two treatments and provides nurses with the knowledge to explain the use of GnRH antagonists to patients and administer this therapy effectively.
- Subjects
LUTEINIZING hormone releasing hormone antagonists; ANTINEOPLASTIC agents; LUTEINIZING hormone releasing hormone; PROSTATE tumors; TESTOSTERONE; PHARMACODYNAMICS; THERAPEUTICS
- Publication
Nursing Standard, 2014, Vol 28, Issue 23, p44
- ISSN
0029-6570
- Publication type
Journal Article
- DOI
10.7748/ns2014.02.28.23.44.e7823